ImmunoPrecise Antibodies Ltd.ImmunoPrecise Antibodies Ltd.ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd.

No trades
See on Supercharts
Market capitalization
‪32.63 M‬USD
−0.42USD
‪−19.97 M‬USD
‪15.54 M‬USD
‪21.53 M‬
Beta (1Y)
−0.69

About ImmunoPrecise Antibodies Ltd.

CEO
Jennifer L. Bath
Headquarters
Victoria
Employees (FY)
102
Founded
1983
ISIN
CA45257F2008
FIGI
BBG000CR68W7
ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IPA is 1.28 USD — it has increased by 3.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ImmunoPrecise Antibodies Ltd. stocks are traded under the ticker IPA.
ImmunoPrecise Antibodies Ltd. is going to release the next earnings report on Jul 5, 2024. Keep track of upcoming events with our Earnings Calendar.
IPA stock is 5.49% volatile and has beta coefficient of −0.69. Check out the list of the most volatile stocks — is ImmunoPrecise Antibodies Ltd. there?
One year price forecast for ImmunoPrecise Antibodies Ltd. has a max estimate of 8.99 USD and a min estimate of 4.99 USD.
IPA earnings for the last quarter are −0.07 USD per share, whereas the estimation was −0.09 USD resulting in a 23.08% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about ImmunoPrecise Antibodies Ltd. earnings.
ImmunoPrecise Antibodies Ltd. revenue for the last quarter amounts to ‪4.47 M‬ USD despite the estimated figure of ‪4.22 M‬ USD. In the next quarter revenue is expected to reach ‪4.51 M‬ USD.
Yes, you can track ImmunoPrecise Antibodies Ltd. financials in yearly and quarterly reports right on TradingView.
IPA stock has fallen by 5.88% compared to the previous week, the month change is a 5.19% fall, over the last year ImmunoPrecise Antibodies Ltd. has showed a 51.52% decrease.
IPA net income for the last quarter is ‪−2.17 M‬ USD, while the quarter before that showed ‪−1.93 M‬ USD of net income which accounts for −12.60% change. Track more ImmunoPrecise Antibodies Ltd. financial stats to get the full picture.
Today ImmunoPrecise Antibodies Ltd. has the market capitalization of ‪30.92 M‬, it has decreased by 3.40% over the last week.
No, IPA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IPA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ImmunoPrecise Antibodies Ltd. stock right from TradingView charts — choose your broker and connect to your account.
IPA reached its all-time high on Dec 30, 2020 with the price of 33.34 USD, and its all-time low was 0.02 USD and was reached on Dec 4, 2015.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 102.00 employees. See our rating of the largest employees — is ImmunoPrecise Antibodies Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ImmunoPrecise Antibodies Ltd. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ImmunoPrecise Antibodies Ltd. stock shows the strong sell signal. See more of ImmunoPrecise Antibodies Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ImmunoPrecise Antibodies Ltd. future price: according to them, IPA price has a max estimate of 8.99 USD and a min estimate of 4.99 USD. Read a more detailed ImmunoPrecise Antibodies Ltd. forecast: see what analysts think of ImmunoPrecise Antibodies Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ImmunoPrecise Antibodies Ltd. EBITDA is ‪−7.76 M‬ USD, and current EBITDA margin is −105.81%. See more stats in ImmunoPrecise Antibodies Ltd. financial statements.